![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
Stephen V Liu, MD
@StephenVLiu
Director of Thoracic Oncology & Developmental Therapeutics @Georgetown @LombardiCancer; Host @IASLC Podcast; Co-Chair #DCLung24 #TexasLung25 #HereWeGo
ID:377425889
https://www.medstarhealth.org/doctors/stephen-liu-md 21-09-2011 15:17:53
17,7K Tweets
24,4K Followers
3,0K Following
![Jennifer Marks, MD(@jennifermarksmd) 's Twitter Profile Photo Jennifer Marks, MD(@jennifermarksmd) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1665861567987044355/sEfRm5AL_200x200.jpg)
![OncLive.com(@OncLive) 's Twitter Profile Photo OncLive.com(@OncLive) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1207309207004950533/hnCTQqRs_200x200.jpg)
In this episode of #OncLiveOnAir , experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 ASCO Meeting. Stephen V Liu, MD Sumanta K. Pal, MD, FASCO Dr. Shubham Pant Vincent Rajkumar #ASCO2024 onclive.com/view/oncology-…
![OncLive.com (@OncLive) on Twitter photo 2024-05-23 18:02:05 In this episode of #OncLiveOnAir, experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 @ASCO Meeting. @StephenVLiu @montypal @DrShubhamPant @VincentRK #ASCO2024 onclive.com/view/oncology-… In this episode of #OncLiveOnAir, experts from across oncology specialties discuss the abstracts and presentations they are most looking forward to seeing at the 2024 @ASCO Meeting. @StephenVLiu @montypal @DrShubhamPant @VincentRK #ASCO2024 onclive.com/view/oncology-…](https://pbs.twimg.com/media/GOSEPQUXIAIVtOG.jpg)
![Oncogene Cancer Research(@OncogeneCancer) 's Twitter Profile Photo Oncogene Cancer Research(@OncogeneCancer) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1718931566489997312/y6aOxmU3_200x200.jpg)
The ongoing development of Nuvalent’s zidesamtinib (NVL-520) is an important step forward for our ROS-1 #lungcancer & #cancer community. Here Dr Stephen V Liu, MD highlights the great promise & limited low grade toxicities.
onclive.com/view/dr-liu-on…
#lcsm ROS1ders UK The ROS1ders, Inc.
![Waël Hanna(@wc_hanna) 's Twitter Profile Photo Waël Hanna(@wc_hanna) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1088554313700466688/V4rqhQ7N_200x200.jpg)
Looking forward to hearing more about these studies.
'Dr Stephen V Liu, MD Previews ASCO 2024 Lung Cancer Data'
onclive.com/view/dr-liu-pr… via @onclive
![Waël Hanna (@wc_hanna) on Twitter photo 2024-05-21 19:00:00 Looking forward to hearing more about these studies. 'Dr @StephenVLiu Previews ASCO 2024 Lung Cancer Data' onclive.com/view/dr-liu-pr… via @onclive Looking forward to hearing more about these studies. 'Dr @StephenVLiu Previews ASCO 2024 Lung Cancer Data' onclive.com/view/dr-liu-pr… via @onclive](https://pbs.twimg.com/media/GOGWtFaXQAAMVK4.jpg)
![IASLC(@IASLC) 's Twitter Profile Photo IASLC(@IASLC) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1760755879920721920/Hb7p-RrG_200x200.jpg)
In this virtual tumor board episode of #LungCancerConsidered , host Stephen V Liu, MD leads a discussion about the management of metastatic PD-L1 low #NSCLC . W/guests Apar Kishor Ganti, from University of Nebraska Medical Center, & Dr. Sze Wai Chan, from the Sandton Oncology Centre. Listen Now: bit.ly/PDL1NSCLC24 #LCSM
![IASLC (@IASLC) on Twitter photo 2024-05-21 13:30:14 In this virtual tumor board episode of #LungCancerConsidered, host @StephenVLiu leads a discussion about the management of metastatic PD-L1 low #NSCLC. W/guests @AparGanti, from @unmc, & Dr. Sze Wai Chan, from the Sandton Oncology Centre. Listen Now: bit.ly/PDL1NSCLC24 #LCSM In this virtual tumor board episode of #LungCancerConsidered, host @StephenVLiu leads a discussion about the management of metastatic PD-L1 low #NSCLC. W/guests @AparGanti, from @unmc, & Dr. Sze Wai Chan, from the Sandton Oncology Centre. Listen Now: bit.ly/PDL1NSCLC24 #LCSM](https://pbs.twimg.com/media/GOGy2d3WsAEzSgy.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
Report of real-world 5-year survival with 1L pembrolizumab in PD-L1 high NSCLC Clinical Lung Cancer. With median f/u 60.5m, median OS 19.2m, 5y OS rate 25.1%. Also noted 33% received subsequent therapy. Great real world collaboration with Dr. Vamsi Velcheti, MD MBA.
clinical-lung-cancer.com/article/S1525-…
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
![Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo Drew Moghanaki 🐕(@DrewMoghanaki) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1567709225929031680/ZLzptl93_200x200.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
Looking forward to discussing Targeted Therapy in NSCLC at the UPMC Hillman Cancer Center Pittsburgh Annual Oncology Symposium on Friday August 23, 2024. Great lung sessions with Drs. Liza Villaruz, Mark Socinski, Tim Burns, and Sudhamshi Toom. Hope to see you there!
![Stephen V Liu, MD (@StephenVLiu) on Twitter photo 2024-05-20 13:39:11 Looking forward to discussing Targeted Therapy in NSCLC at the @UPMCHillmanCC Pittsburgh Annual Oncology Symposium on Friday August 23, 2024. Great lung sessions with Drs. Liza Villaruz, Mark Socinski, Tim Burns, and @SudhamshiToom. Hope to see you there! Looking forward to discussing Targeted Therapy in NSCLC at the @UPMCHillmanCC Pittsburgh Annual Oncology Symposium on Friday August 23, 2024. Great lung sessions with Drs. Liza Villaruz, Mark Socinski, Tim Burns, and @SudhamshiToom. Hope to see you there!](https://pbs.twimg.com/media/GOBqgKxWQAAsS8h.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
![A/Prof Tom John(@TommyJohn00) 's Twitter Profile Photo A/Prof Tom John(@TommyJohn00) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1683047305103151110/s5W1wBPH_200x200.jpg)
![Sandip Patel MD(@PatelOncology) 's Twitter Profile Photo Sandip Patel MD(@PatelOncology) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1675628853950316544/8NpH7xVR_200x200.jpg)
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)
Electronic nose tech uses exhaled volatile organic compounds and is being studied as a way to detect early stage lung cancers. Report of E-nose performance in pts with suspected stage I NSCLC JTO & JTO CRR shows promise. Can this complement CT screening?
jto.org/article/S1556-…
![Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1764739949121712128/Y2ydZQbb_200x200.jpg)